AFM
ACET icon

Anson Funds Management’s Adicet Bio ACET Stock Holding History

Anson Funds Management’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-3,463
Closed -$834K – 89
2020
Q2 		$834K Buy
+3,463
New +$680K 0.21% 51

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Anson Funds Management's ACET Position: Q3 2020 in Review

Anson Funds Management sold out of Adicet Bio (ACET) in Q3 2020, closing a stake of 3,463 shares — an estimated $834K sold.

Anson Funds Management first reported a position in ACET in Q2 2020 and held it in 1 quarter. The position peaked at $834K in Q2 2020. 32 funds tracked by Wall St. Rank hold ACET as of Q3 2020.

  • Anson Funds Management reported no remaining Adicet Bio position as of Q3 2020 after selling out during the quarter.
  • Anson Funds Management sold 3,463 Adicet Bio shares in Q3 2020, an estimated $834K.
  • Anson Funds Management first reported a position in Adicet Bio in Q2 2020 and held it in 1 quarter.
  • Anson Funds Management's Adicet Bio position peaked at $834K in Q2 2020.
  • 32 funds tracked by Wall St. Rank held Adicet Bio as of Q3 2020.

Based on Anson Funds Management's 13F filing for Q3 2020, filed 16 Nov 2020.